Global Hip Osteoarthritis Pain Drug Market Research Report 2020

Publisher Name :
Date: 11-Feb-2020
No. of pages: 121
Inquire Before Buying

This report focuses on Hip Osteoarthritis Pain Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hip Osteoarthritis Pain Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

- Pfizer

- Johnson and Johnson

- GlaxoSmithKline

- Bayer

- Eli Lilly

- Novartis

- Sanofi

- Horizon Pharma

- Abbott

- Mylan

- Daiichi Sankyo

- TEVA

- Almatica Pharma

- Astellas Pharma

- Tide Pharmaceutical

- Iroko Pharmaceuticals

- Hengrui Pharmaceutical

- Abiogen Pharma

Segment by Regions

- North America

- Europe

- China

- Japan

Segment by Type

- Oral

- Injection

- External

Segment by Application

- Medical Care

- Personal Care

Global Hip Osteoarthritis Pain Drug Market Research Report 2020

Table of Contents
1 Hip Osteoarthritis Pain Drug Market Overview
1.1 Product Overview and Scope of Hip Osteoarthritis Pain Drug
1.2 Hip Osteoarthritis Pain Drug Segment by Type
1.2.1 Global Hip Osteoarthritis Pain Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Hip Osteoarthritis Pain Drug Segment by Application
1.3.1 Hip Osteoarthritis Pain Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Hip Osteoarthritis Pain Drug Market Size Estimates and Forecasts
1.4.1 Global Hip Osteoarthritis Pain Drug Revenue 2015-2026
1.4.2 Global Hip Osteoarthritis Pain Drug Sales 2015-2026
1.4.3 Hip Osteoarthritis Pain Drug Market Size by Region: 2020 Versus 2026
2 Global Hip Osteoarthritis Pain Drug Market Competition by Manufacturers
2.1 Global Hip Osteoarthritis Pain Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Hip Osteoarthritis Pain Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Hip Osteoarthritis Pain Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Hip Osteoarthritis Pain Drug Manufacturing Sites, Area Served, Product Type
2.5 Hip Osteoarthritis Pain Drug Market Competitive Situation and Trends
2.5.1 Hip Osteoarthritis Pain Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Hip Osteoarthritis Pain Drug Players (Opinion Leaders)
3 Hip Osteoarthritis Pain Drug Retrospective Market Scenario by Region
3.1 Global Hip Osteoarthritis Pain Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Hip Osteoarthritis Pain Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Hip Osteoarthritis Pain Drug Market Facts & Figures by Country
3.3.1 North America Hip Osteoarthritis Pain Drug Sales by Country
3.3.2 North America Hip Osteoarthritis Pain Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Hip Osteoarthritis Pain Drug Market Facts & Figures by Country
3.4.1 Europe Hip Osteoarthritis Pain Drug Sales by Country
3.4.2 Europe Hip Osteoarthritis Pain Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hip Osteoarthritis Pain Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Hip Osteoarthritis Pain Drug Sales by Region
3.5.2 Asia Pacific Hip Osteoarthritis Pain Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Hip Osteoarthritis Pain Drug Market Facts & Figures by Country
3.6.1 Latin America Hip Osteoarthritis Pain Drug Sales by Country
3.6.2 Latin America Hip Osteoarthritis Pain Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Hip Osteoarthritis Pain Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Country
3.7.2 Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Hip Osteoarthritis Pain Drug Historic Market Analysis by Type
4.1 Global Hip Osteoarthritis Pain Drug Sales Market Share by Type (2015-2020)
4.2 Global Hip Osteoarthritis Pain Drug Revenue Market Share by Type (2015-2020)
4.3 Global Hip Osteoarthritis Pain Drug Price Market Share by Type (2015-2020)
4.4 Global Hip Osteoarthritis Pain Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Hip Osteoarthritis Pain Drug Historic Market Analysis by Application
5.1 Global Hip Osteoarthritis Pain Drug Sales Market Share by Application (2015-2020)
5.2 Global Hip Osteoarthritis Pain Drug Revenue Market Share by Application (2015-2020)
5.3 Global Hip Osteoarthritis Pain Drug Price by Application (2015-2020)
6 Company Profiles and Key Figures in Hip Osteoarthritis Pain Drug Business
6.1 Pfizer
6.1.1 Corporation Information
6.1.2 Pfizer Description, Business Overview and Total Revenue
6.1.3 Pfizer Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Pfizer Products Offered
6.1.5 Pfizer Recent Development
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.2.2 Johnson and Johnson Description, Business Overview and Total Revenue
6.2.3 Johnson and Johnson Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Johnson and Johnson Products Offered
6.2.5 Johnson and Johnson Recent Development
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.3.2 GlaxoSmithKline Description, Business Overview and Total Revenue
6.3.3 GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 GlaxoSmithKline Products Offered
6.3.5 GlaxoSmithKline Recent Development
6.4 Bayer
6.4.1 Bayer Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.4.2 Bayer Description, Business Overview and Total Revenue
6.4.3 Bayer Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Bayer Products Offered
6.4.5 Bayer Recent Development
6.5 Eli Lilly
6.5.1 Eli Lilly Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.5.2 Eli Lilly Description, Business Overview and Total Revenue
6.5.3 Eli Lilly Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Eli Lilly Products Offered
6.5.5 Eli Lilly Recent Development
6.6 Novartis
6.6.1 Novartis Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.6.2 Novartis Description, Business Overview and Total Revenue
6.6.3 Novartis Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Novartis Products Offered
6.6.5 Novartis Recent Development
6.7 Sanofi
6.6.1 Sanofi Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.6.2 Sanofi Description, Business Overview and Total Revenue
6.6.3 Sanofi Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sanofi Products Offered
6.7.5 Sanofi Recent Development
6.8 Horizon Pharma
6.8.1 Horizon Pharma Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.8.2 Horizon Pharma Description, Business Overview and Total Revenue
6.8.3 Horizon Pharma Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Horizon Pharma Products Offered
6.8.5 Horizon Pharma Recent Development
6.9 Abbott
6.9.1 Abbott Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.9.2 Abbott Description, Business Overview and Total Revenue
6.9.3 Abbott Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Abbott Products Offered
6.9.5 Abbott Recent Development
6.10 Mylan
6.10.1 Mylan Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.10.2 Mylan Description, Business Overview and Total Revenue
6.10.3 Mylan Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Mylan Products Offered
6.10.5 Mylan Recent Development
6.11 Daiichi Sankyo
6.11.1 Daiichi Sankyo Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.11.2 Daiichi Sankyo Hip Osteoarthritis Pain Drug Description, Business Overview and Total Revenue
6.11.3 Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Daiichi Sankyo Products Offered
6.11.5 Daiichi Sankyo Recent Development
6.12 TEVA
6.12.1 TEVA Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.12.2 TEVA Hip Osteoarthritis Pain Drug Description, Business Overview and Total Revenue
6.12.3 TEVA Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.12.4 TEVA Products Offered
6.12.5 TEVA Recent Development
6.13 Almatica Pharma
6.13.1 Almatica Pharma Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.13.2 Almatica Pharma Hip Osteoarthritis Pain Drug Description, Business Overview and Total Revenue
6.13.3 Almatica Pharma Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Almatica Pharma Products Offered
6.13.5 Almatica Pharma Recent Development
6.14 Astellas Pharma
6.14.1 Astellas Pharma Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.14.2 Astellas Pharma Hip Osteoarthritis Pain Drug Description, Business Overview and Total Revenue
6.14.3 Astellas Pharma Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Astellas Pharma Products Offered
6.14.5 Astellas Pharma Recent Development
6.15 Tide Pharmaceutical
6.15.1 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.15.2 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Description, Business Overview and Total Revenue
6.15.3 Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Tide Pharmaceutical Products Offered
6.15.5 Tide Pharmaceutical Recent Development
6.16 Iroko Pharmaceuticals
6.16.1 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.16.2 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Description, Business Overview and Total Revenue
6.16.3 Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.16.4 Iroko Pharmaceuticals Products Offered
6.16.5 Iroko Pharmaceuticals Recent Development
6.17 Hengrui Pharmaceutical
6.17.1 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.17.2 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Description, Business Overview and Total Revenue
6.17.3 Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.17.4 Hengrui Pharmaceutical Products Offered
6.17.5 Hengrui Pharmaceutical Recent Development
6.18 Abiogen Pharma
6.18.1 Abiogen Pharma Hip Osteoarthritis Pain Drug Production Sites and Area Served
6.18.2 Abiogen Pharma Hip Osteoarthritis Pain Drug Description, Business Overview and Total Revenue
6.18.3 Abiogen Pharma Hip Osteoarthritis Pain Drug Sales, Revenue and Gross Margin (2015-2020)
6.18.4 Abiogen Pharma Products Offered
6.18.5 Abiogen Pharma Recent Development
7 Hip Osteoarthritis Pain Drug Manufacturing Cost Analysis
7.1 Hip Osteoarthritis Pain Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hip Osteoarthritis Pain Drug
7.4 Hip Osteoarthritis Pain Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hip Osteoarthritis Pain Drug Distributors List
8.3 Hip Osteoarthritis Pain Drug Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Hip Osteoarthritis Pain Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hip Osteoarthritis Pain Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Hip Osteoarthritis Pain Drug by Type (2021-2026)
10.2 Hip Osteoarthritis Pain Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hip Osteoarthritis Pain Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Hip Osteoarthritis Pain Drug by Application (2021-2026)
10.3 Hip Osteoarthritis Pain Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hip Osteoarthritis Pain Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Hip Osteoarthritis Pain Drug by Region (2021-2026)
10.4 North America Hip Osteoarthritis Pain Drug Estimates and Projections (2021-2026)
10.5 Europe Hip Osteoarthritis Pain Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Hip Osteoarthritis Pain Drug Estimates and Projections (2021-2026)
10.7 Latin America Hip Osteoarthritis Pain Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Hip Osteoarthritis Pain Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Hip Osteoarthritis Pain Drug Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Hip Osteoarthritis Pain Drug Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Hip Osteoarthritis Pain Drug Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Hip Osteoarthritis Pain Drug Manufacturers Covered in This Study
Table 5. Global Hip Osteoarthritis Pain Drug Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Hip Osteoarthritis Pain Drug Sales Share by Manufacturers (2015-2020)
Table 7. Global Hip Osteoarthritis Pain Drug Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Hip Osteoarthritis Pain Drug Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Hip Osteoarthritis Pain Drug Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Hip Osteoarthritis Pain Drug Sales Sites and Area Served
Table 11. Manufacturers Hip Osteoarthritis Pain Drug Product Types
Table 12. Global Hip Osteoarthritis Pain Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hip Osteoarthritis Pain Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hip Osteoarthritis Pain Drug as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Hip Osteoarthritis Pain Drug Players
Table 16. Global Hip Osteoarthritis Pain Drug Sales (K Units) by Region (2015-2020)
Table 17. Global Hip Osteoarthritis Pain Drug Sales Market Share by Region (2015-2020)
Table 18. Global Hip Osteoarthritis Pain Drug Revenue (Million US$) by Region (2015-2020)
Table 19. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Region (2015-2020)
Table 20. North America Hip Osteoarthritis Pain Drug Sales by Country (2015-2020) (K Units)
Table 21. North America Hip Osteoarthritis Pain Drug Sales Market Share by Country (2015-2020)
Table 22. North America Hip Osteoarthritis Pain Drug Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2015-2020)
Table 24. Europe Hip Osteoarthritis Pain Drug Sales by Country (2015-2020) (K Units)
Table 25. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Country (2015-2020)
Table 26. Europe Hip Osteoarthritis Pain Drug Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Hip Osteoarthritis Pain Drug Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Hip Osteoarthritis Pain Drug Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Hip Osteoarthritis Pain Drug Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Hip Osteoarthritis Pain Drug Revenue Market Share by Region (2015-2020)
Table 32. Latin America Hip Osteoarthritis Pain Drug Sales by Country (2015-2020) (K Units)
Table 33. Latin America Hip Osteoarthritis Pain Drug Sales Market Share by Country (2015-2020)
Table 34. Latin America Hip Osteoarthritis Pain Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Hip Osteoarthritis Pain Drug Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Hip Osteoarthritis Pain Drug Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Hip Osteoarthritis Pain Drug Revenue Market Share by Country (2015-2020)
Table 40. Global Hip Osteoarthritis Pain Drug Sales (K Units) by Type (2015-2020)
Table 41. Global Hip Osteoarthritis Pain Drug Sales Share by Type (2015-2020)
Table 42. Global Hip Osteoarthritis Pain Drug Revenue (Million US$) by Type (2015-2020)
Table 43. Global Hip Osteoarthritis Pain Drug Revenue Share by Type (2015-2020)
Table 44. Global Hip Osteoarthritis Pain Drug Price (USD/Unit) by Type (2015-2020)
Table 45. Global Hip Osteoarthritis Pain Drug Sales (K Units) by Application (2015-2020)
Table 46. Global Hip Osteoarthritis Pain Drug Sales Market Share by Application (2015-2020)
Table 47. Global Hip Osteoarthritis Pain Drug Sales Growth Rate by Application (2015-2020)
Table 48. Pfizer Hip Osteoarthritis Pain Drug Corporation Information
Table 49. Pfizer Description and Business Overview
Table 50. Pfizer Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Pfizer Main Product
Table 52. Pfizer Recent Development
Table 53. Johnson and Johnson Hip Osteoarthritis Pain Drug Corporation Information
Table 54. Johnson and Johnson Corporation Information
Table 55. Johnson and Johnson Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Johnson and Johnson Main Product
Table 57. Johnson and Johnson Recent Development
Table 58. GlaxoSmithKline Hip Osteoarthritis Pain Drug Corporation Information
Table 59. GlaxoSmithKline Corporation Information
Table 60. GlaxoSmithKline Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. GlaxoSmithKline Main Product
Table 62. GlaxoSmithKline Recent Development
Table 63. Bayer Hip Osteoarthritis Pain Drug Corporation Information
Table 64. Bayer Corporation Information
Table 65. Bayer Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Bayer Main Product
Table 67. Bayer Recent Development
Table 68. Eli Lilly Hip Osteoarthritis Pain Drug Corporation Information
Table 69. Eli Lilly Corporation Information
Table 70. Eli Lilly Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Eli Lilly Main Product
Table 72. Eli Lilly Recent Development
Table 73. Novartis Hip Osteoarthritis Pain Drug Corporation Information
Table 74. Novartis Corporation Information
Table 75. Novartis Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Novartis Main Product
Table 77. Novartis Recent Development
Table 78. Sanofi Hip Osteoarthritis Pain Drug Corporation Information
Table 79. Sanofi Corporation Information
Table 80. Sanofi Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Sanofi Main Product
Table 82. Sanofi Recent Development
Table 83. Horizon Pharma Hip Osteoarthritis Pain Drug Corporation Information
Table 84. Horizon Pharma Corporation Information
Table 85. Horizon Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Horizon Pharma Main Product
Table 87. Horizon Pharma Recent Development
Table 88. Abbott Hip Osteoarthritis Pain Drug Corporation Information
Table 89. Abbott Corporation Information
Table 90. Abbott Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Abbott Main Product
Table 92. Abbott Recent Development
Table 93. Mylan Hip Osteoarthritis Pain Drug Corporation Information
Table 94. Mylan Corporation Information
Table 95. Mylan Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Mylan Main Product
Table 97. Mylan Recent Development
Table 98. Daiichi Sankyo Hip Osteoarthritis Pain Drug Corporation Information
Table 99. Daiichi Sankyo Corporation Information
Table 100. Daiichi Sankyo Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 101. Daiichi Sankyo Main Product
Table 102. Daiichi Sankyo Recent Development
Table 103. TEVA Hip Osteoarthritis Pain Drug Corporation Information
Table 104. TEVA Corporation Information
Table 105. TEVA Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. TEVA Main Product
Table 107. TEVA Recent Development
Table 108. Almatica Pharma Hip Osteoarthritis Pain Drug Corporation Information
Table 109. Almatica Pharma Corporation Information
Table 110. Almatica Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 111. Almatica Pharma Main Product
Table 112. Almatica Pharma Recent Development
Table 113. Astellas Pharma Hip Osteoarthritis Pain Drug Corporation Information
Table 114. Astellas Pharma Corporation Information
Table 115. Astellas Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 116. Astellas Pharma Main Product
Table 117. Astellas Pharma Recent Development
Table 118. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Corporation Information
Table 119. Tide Pharmaceutical Corporation Information
Table 120. Tide Pharmaceutical Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 121. Tide Pharmaceutical Main Product
Table 122. Tide Pharmaceutical Recent Development
Table 123. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Corporation Information
Table 124. Iroko Pharmaceuticals Corporation Information
Table 125. Iroko Pharmaceuticals Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 126. Iroko Pharmaceuticals Main Product
Table 127. Iroko Pharmaceuticals Recent Development
Table 128. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Corporation Information
Table 129. Hengrui Pharmaceutical Corporation Information
Table 130. Hengrui Pharmaceutical Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 131. Hengrui Pharmaceutical Main Product
Table 132. Hengrui Pharmaceutical Recent Development
Table 133. Abiogen Pharma Hip Osteoarthritis Pain Drug Corporation Information
Table 134. Abiogen Pharma Corporation Information
Table 135. Abiogen Pharma Hip Osteoarthritis Pain Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 136. Abiogen Pharma Main Product
Table 137. Abiogen Pharma Recent Development
Table 138. Sales Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Hip Osteoarthritis Pain Drug Distributors List
Table 141. Hip Osteoarthritis Pain Drug Customers List
Table 142. Market Key Trends
Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 144. Key Challenges
Table 145. Global Hip Osteoarthritis Pain Drug Sales (K Units) Forecast by Type (2021-2026)
Table 146. Global Hip Osteoarthritis Pain Drug Sales Market Share Forecast by Type (2021-2026)
Table 147. Global Hip Osteoarthritis Pain Drug Revenue (Million US$) Forecast by Type (2021-2026)
Table 148. Global Hip Osteoarthritis Pain Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 149. Global Hip Osteoarthritis Pain Drug Sales (K Units) Forecast by Application (2021-2026)
Table 150. Global Hip Osteoarthritis Pain Drug Revenue (Million US$) Forecast by Application (2021-2026)
Table 151. Global Hip Osteoarthritis Pain Drug Sales (K Units) Forecast by Region (2021-2026)
Table 152. Global Hip Osteoarthritis Pain Drug Sales Market Share Forecast by Region (2021-2026)
Table 153. Global Hip Osteoarthritis Pain Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 154. Global Hip Osteoarthritis Pain Drug Revenue Market Share Forecast by Region (2021-2026)
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Hip Osteoarthritis Pain Drug
Figure 2. Global Hip Osteoarthritis Pain Drug Sales Market Share by Type: 2020 VS 2026
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. External Product Picture
Figure 6. Global Hip Osteoarthritis Pain Drug Consumption Market Share by Application: 2020 VS 2026
Figure 7. Medical Care
Figure 8. Personal Care
Figure 9. Global Hip Osteoarthritis Pain Drug Market Size 2015-2026 (US$ Million)
Figure 10. Global Hip Osteoarthritis Pain Drug Sales Capacity (K Units) (2015-2026)
Figure 11. Global Hip Osteoarthritis Pain Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Hip Osteoarthritis Pain Drug Sales Share by Manufacturers in 2020
Figure 13. Global Hip Osteoarthritis Pain Drug Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Hip Osteoarthritis Pain Drug Revenue in 2019
Figure 15. Hip Osteoarthritis Pain Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Hip Osteoarthritis Pain Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Hip Osteoarthritis Pain Drug Sales Market Share by Region in 2019
Figure 18. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Hip Osteoarthritis Pain Drug Revenue Market Share by Region in 2019
Figure 20. North America Hip Osteoarthritis Pain Drug Sales Market Share by Country in 2019
Figure 21. North America Hip Osteoarthritis Pain Drug Revenue Market Share by Country in 2019
Figure 22. U.S. Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 23. U.S. Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 25. Canada Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Hip Osteoarthritis Pain Drug Sales Market Share by Country in 2019
Figure 27. Europe Hip Osteoarthritis Pain Drug Revenue Market Share by Country in 2019
Figure 28. Germany Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 29. Germany Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 31. France Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.K. Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 35. Italy Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 37. Russia Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Hip Osteoarthritis Pain Drug Sales Market Share by Region in 2019
Figure 39. Asia Pacific Hip Osteoarthritis Pain Drug Revenue Market Share by Region in 2019
Figure 40. China Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 41. China Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 43. Japan Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 47. India Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 49. Australia Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 51. Taiwan Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 53. Indonesia Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 55. Thailand Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 57. Malaysia Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 59. Philippines Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 61. Vietnam Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Hip Osteoarthritis Pain Drug Sales Market Share by Country in 2019
Figure 63. Latin America Hip Osteoarthritis Pain Drug Revenue Market Share by Country in 2019
Figure 64. Mexico Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 65. Mexico Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 67. Brazil Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 69. Argentina Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Hip Osteoarthritis Pain Drug Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Hip Osteoarthritis Pain Drug Revenue Market Share by Country in 2019
Figure 72. Turkey Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 73. Turkey Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 75. Saudi Arabia Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Hip Osteoarthritis Pain Drug Sales Growth Rate (2015-2020) (K Units)
Figure 77. U.A.E Hip Osteoarthritis Pain Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Hip Osteoarthritis Pain Drug by Type (2015-2020)
Figure 79. Sales Market Share of Hip Osteoarthritis Pain Drug by Type in 2019
Figure 80. Revenue Share of Hip Osteoarthritis Pain Drug by Type (2015-2020)
Figure 81. Revenue Market Share of Hip Osteoarthritis Pain Drug by Type in 2019
Figure 82. Global Hip Osteoarthritis Pain Drug Sales Growth by Type (2015-2020) (K Units)
Figure 83. Global Hip Osteoarthritis Pain Drug Sales Market Share by Application (2015-2020)
Figure 84. Global Hip Osteoarthritis Pain Drug Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Hip Osteoarthritis Pain Drug by Application (2015-2020)
Figure 86. Global Revenue Share of Hip Osteoarthritis Pain Drug by Application in 2020
Figure 87. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Johnson and Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Bayer Total Revenue (US$ Million): 2019
  • Global Antihemorrhagic Agent Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 102
    Market Overview The global Antihemorrhagic Agent market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Antihemorrhagic Agent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales an......
  • Global PVA Embolization Particles Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 102
    Market Overview The global PVA Embolization Particles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The PVA Embolization Particles market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape......
  • Global Bisoprolol Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 100
    Market Overview The global Bisoprolol market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bisoprolol market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of dome......
  • Global Sotalol Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 105
    Market Overview The global Sotalol market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sotalol market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic a......
  • Global Amiodarone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 102
    Market Overview The global Amiodarone market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Amiodarone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of dome......
  • Global Physiological Seawater Nasal Spray Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 102
    Market Overview The global Physiological Seawater Nasal Spray market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Physiological Seawater Nasal Spray market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, compe......
  • Global Disintegrants Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 26-Feb-2020        Price: US 3480 Onwards        Pages: 109
    Market Overview The global Disintegrants market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Disintegrants market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact o......
  • Global Enteric Coating Market Research Report 2020
    Published: 25-Feb-2020        Price: US 2900 Onwards        Pages: 91
    This report focuses on Enteric Coating volume and value at global level, regional level and company level. From a global perspective, this report represents overall Enteric Coating market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.......
  • Global Nattokinase Supplements Market Research Report 2020
    Published: 25-Feb-2020        Price: US 2900 Onwards        Pages: 121
    This report focuses on Nattokinase Supplements volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nattokinase Supplements market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs